According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.

Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of treating deep vein thrombosis (DVT), suggests data being presented at the 25th annual International Symposium on Endovascular Therapy (ISET).

St. Jude Medical Inc. announced European CE mark approval of its ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Designed for control and maneuverability during complex cardiac ablation procedures, the technology will be on display at the eighteenth annual Boston AF Symposium.

Peri-natal systems real-time clinical decision support company PeriGen Inc. announced the results of an independent validation study on fetal ECG strip interpretation favorably comparing PeriGen PeriCALM Patterns software with the findings of three experts from the National Institute of Health (NIH). The U.S. Food and Drug Administration (FDA)-cleared fetal strip interpretation technology is a component of the company's perinatal central surveillance offering.

C-section Hysterectomy Clinical trial Interventional Radiology Balloon Catheter

Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while preventing hysterectomy and preserving fertility, suggests research being presented at the 25th annual International Symposium on Endovascular Therapy (ISET).

Cordis Corporation announced the presentation of the two-year STROLL study results at the Abstracts and Late Breaking Clinical Trials session at ISET 2013.

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved, with conditions, the ProMRI clinical trial via an Investigational Device Exemption. Biotronik is sponsoring the trial (NCT01761162) and has already initiated U.S. site recruitment. The ProMRI clinical trial is designed to recruit 245 subjects implanted with one of Biotronik’s cardiac devices that include ProMRI technology at 30 U.S. investigational centers.

GNAX Health announced the availability of GNAX SDEX Secure digital imaging and communications in medicine (DICOM) Exchange, allowing hospitals, ACOs and HIEs the ability to transfer medical images securely. The announcement was made by Jeff Hinkle, CEO, GNAX, at the Radiological Society of North America's 98th Scientific Assembly and Annual Meeting in Chicago, Ill.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now